SABA inhaler carbon emissions drop by one-third
NHS England data has shown that average emissions for short-acting beta-2 agonist (SABA) inhalers prescribed in primary care declined by 33% between 2020 and November 2024 — from 24.2 kgCO2e to 16.1 kgCO2e. The Pharmaceutical Journal reports that this fall in SABA inhaler emissions most likely owes to patients switching from the Ventolin Evohaler to the Salamol inhaler.
NICE has produced a decision aid on asthma inhalers and climate change. It explains the options for patients thinking about reducing the carbon footprint of their asthma treatment and the options available.
Related Posts
Buying Group Recruitment Support
The LMC Buying Group understand that recruitment is often an expensive and time-consuming business, so they created an eye-catching, easy…
Safe Working in General Practice Guidance
General practice is in crisis. GPs are faced with increasingly unsafe workloads coupled with a rapidly diminishing and exhausted workforce….
